Mark Taylor

1.0k total citations
12 papers, 843 citations indexed

About

Mark Taylor is a scholar working on Physiology, Molecular Biology and Biomaterials. According to data from OpenAlex, Mark Taylor has authored 12 papers receiving a total of 843 indexed citations (citations by other indexed papers that have themselves been cited), including 9 papers in Physiology, 4 papers in Molecular Biology and 4 papers in Biomaterials. Recurrent topics in Mark Taylor's work include Alzheimer's disease research and treatments (9 papers), Supramolecular Self-Assembly in Materials (4 papers) and Parkinson's Disease Mechanisms and Treatments (2 papers). Mark Taylor is often cited by papers focused on Alzheimer's disease research and treatments (9 papers), Supramolecular Self-Assembly in Materials (4 papers) and Parkinson's Disease Mechanisms and Treatments (2 papers). Mark Taylor collaborates with scholars based in United Kingdom, Japan and Italy. Mark Taylor's co-authors include David Allsop, Nigel J. Fullwood, Susan A. Moore, Penelope G. Foulds, David Mann, Masato Hasegawa, Maria Gregori, Massimo Masserini, David M. A. Mann and Angela Parker and has published in prestigious journals such as PLoS ONE, Biochemistry and The FASEB Journal.

In The Last Decade

Mark Taylor

12 papers receiving 834 citations

Peers

Mark Taylor

PHYSI

NEURO

BIOMA

PHARM

Youssra K. Al‐Hilaly United Kingdom

Christopher J.R. Dunning Sweden

Lara Ordóñez‐Gutiérrez Spain

Ann‐Christin Brorsson Sweden

Dhiman Ghosh India

Pietro La Vitola Italy

Ryan Limbocker United States

Firoz Roshan Kurudenkandy Sweden

Shruti Sahay India

Youssra K. Al‐Hilaly United Kingdom

Mark Taylor

581 ×1.3

PHYSI

479 ×1.5

83 ×0.4

NEURO

114 ×0.6

BIOMA

99 ×0.7

PHARM

Citations per year, relative to Mark Taylor Mark Taylor (= 1×) peers Youssra K. Al‐Hilaly

Countries citing papers authored by Mark Taylor

Since Specialization

Citations

This map shows the geographic impact of Mark Taylor's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Mark Taylor with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Mark Taylor more than expected).

Fields of papers citing papers by Mark Taylor

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Mark Taylor. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Mark Taylor. The network helps show where Mark Taylor may publish in the future.

Co-authorship network of co-authors of Mark Taylor

This figure shows the co-authorship network connecting the top 25 collaborators of Mark Taylor. A scholar is included among the top collaborators of Mark Taylor based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Mark Taylor. Mark Taylor is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

12 of 12 papers shown

Taylor, Mark, et al.. (2018). Liposome delivery systems for the treatment of Alzheimer’s disease. International Journal of Nanomedicine. Volume 13. 8507–8522. 140 indexed citations

Kasai, Takashi, Masaki Kondo, Ryotaro Ishii, et al.. (2017). Aβ levels in the jugular vein and high molecular weight Aβ oligomer levels in CSF can be used as biomarkers to indicate the anti-amyloid effect of IVIg for Alzheimer’s disease. PLoS ONE. 12(4). e0174630–e0174630. 6 indexed citations

Gregori, Maria, Mark Taylor, Elisa Salvati, et al.. (2016). Retro-inverso peptide inhibitor nanoparticles as potent inhibitors of aggregation of the Alzheimer's Aβ peptide. Nanomedicine Nanotechnology Biology and Medicine. 13(2). 723–732. 46 indexed citations

Kaffy, Julia, Dimitri Brinet, Jean‐Louis Soulier, et al.. (2016). Designed Glycopeptidomimetics Disrupt Protein–Protein Interactions Mediating Amyloid β-Peptide Aggregation and Restore Neuroblastoma Cell Viability. Journal of Medicinal Chemistry. 59(5). 2025–2040. 37 indexed citations

Parthsarathy, Vadivel, Paula L. McClean, Christian Hölscher, et al.. (2013). A Novel Retro-Inverso Peptide Inhibitor Reduces Amyloid Deposition, Oxidation and Inflammation and Stimulates Neurogenesis in the APPswe/PS1ΔE9 Mouse Model of Alzheimer’s Disease. PLoS ONE. 8(1). e54769–e54769. 73 indexed citations

Kasai, Takashi, Takahiko Tokuda, Mark Taylor, et al.. (2013). Correlation of Aβ oligomer levels in matched cerebrospinal fluid and serum samples. Neuroscience Letters. 551. 17–22. 24 indexed citations

Kasai, Takashi, Takahiko Tokuda, Mark Taylor, Masanori Nakagawa, & David Allsop. (2012). Utilization of a multiple antigenic peptide as a calibration standard in the BAN50 single antibody sandwich ELISA for Aβ oligomers. Biochemical and Biophysical Research Communications. 422(3). 375–380. 10 indexed citations

Taylor, Mark, Karen Moore, Johanne M. Murray, Stephen J. Aves, & C P Price. (2011). Mcm10 interacts with Rad4/Cut5TopBP1 and its association with origins of DNA replication is dependent on Rad4/Cut5TopBP1. DNA repair. 10(11). 1154–1163. 20 indexed citations

Taylor, Mark, Susan A. Moore, Spyridon Mourtas, et al.. (2011). Effect of curcumin-associated and lipid ligand-functionalized nanoliposomes on aggregation of the Alzheimer's Aβ peptide. Nanomedicine Nanotechnology Biology and Medicine. 7(5). 541–550. 117 indexed citations

10.

Foulds, Penelope G., John Mitchell, Angela Parker, et al.. (2011). Phosphorylated α‐synuclein can be detected in blood plasma and is potentially a useful biomarker for Parkinson's disease. The FASEB Journal. 25(12). 4127–4137. 160 indexed citations

11.

Taylor, Mark, Susan A. Moore, Jennifer Mayes, et al.. (2010). Development of a Proteolytically Stable Retro-Inverso Peptide Inhibitor of β-Amyloid Oligomerization as a Potential Novel Treatment for Alzheimer’s Disease. Biochemistry. 49(15). 3261–3272. 134 indexed citations

12.

Foulds, Penelope G., Yvonne S. Davidson, Manjari Mishra, et al.. (2009). Plasma phosphorylated-TDP-43 protein levels correlate with brain pathology in frontotemporal lobar degeneration. Acta Neuropathologica. 118(5). 647–658. 76 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact